Join date: Feb 8, 2022


The vascular stent market is projected to reach USD 17.68 Billion by 2021 from USD 12.21 Billion in 2016, at a CAGR of 7.7% from 2016 to 2021. Technological advancements in stents, increasing number of angioplasty procedures, rising burden of vascular diseases, increasing demand for minimally invasive procedures, and the rising geriatric population are the major factors driving the growth of the market. Moreover, the development of bioresorbable vascular scaffolds and expansion in emerging markets are expected to offer potential growth opportunities to market players in the coming years. However, the presence of alternative treatment methods for cardiac diseases, stringent regulations for product approval, and numerous cases of product failure and recalls are expected to restrain the growth of the market during the forecast period.


More actions